Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20
  • There is currently no data for OSI

Contract Win

21 Jul 2022 07:00

RNS Number : 2170T
Osirium Technologies PLC
21 July 2022
 

21 July 2022

 

Osirium Technologies plc

("Osirium" or the "Group")

 

New contract win

 

UK university selects Osirium PAM to address cyber insurance needs

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, is pleased to announce a new contract worth c. £140,000 for a three-year subscription for its Privileged Access Management ("PAM") solution with a UK university (the "University").

 

The University has selected the Group's PAM solution to address requirements for improved security for IT system access, especially by third parties. PAM was a key requirement of its cybersecurity insurance provider and will be used to protect 1,000 devices across the establishment.

 

With an accelerated purchase, supported by Osirium's partners Prianto and Academia, the contract was closed within six weeks. The Directors believe that the speed of implementation of PAM and value for money were critical to the selection of Osirium against other cybersecurity vendors.

 

This contract represents 8.9% of the total bookings achieved by the Group in 2021 and reflects the continuing trend of increasing average contract values from the new clients closed in 2022.

 

David Guyatt, Chief Executive Officer of Osirium said:

 

"This is another win for Osirium in higher education, following on from a number of key wins in 2022. We're especially pleased that not only did we compete successfully against larger vendors but, working closely with our partners, we were able to provide the solution the customer needed in a very short period.

 

"This sector remains a key focus for the Group and I'm pleased to see our sales process aided through increased reference sites with existing customers. In collaboration with our channel partner network, we continue to identify and engage with other prospects in this space."

  

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Rupert Hutton, CFO

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

William Ellis Hancock

 

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain. 

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBKKBNKBKBKOB
Date   Source Headline
16th Mar 20225:50 pmRNSHolding(s) in Company
14th Mar 20224:40 pmRNSSecond Price Monitoring Extn
14th Mar 20224:35 pmRNSPrice Monitoring Extension
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
10th Mar 20222:16 pmRNSHolding(s) in Company
10th Mar 202211:06 amRNSSecond Price Monitoring Extn
10th Mar 202211:00 amRNSPrice Monitoring Extension
10th Mar 202210:50 amRNSHolding(s) in Company
7th Mar 20224:44 pmRNSHolding(s) in Company
7th Mar 202212:15 pmRNSResult of General Meeting
2nd Mar 20227:00 amRNSNew Customer Wins
1st Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20225:00 pmRNSTotal Voting Rights
18th Feb 20222:52 pmRNSHolding(s) in Company
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202210:30 amRNSProposed Placing and Subscription and Notice of GM
14th Jan 20227:01 amRNSTrading Update
14th Jan 20227:00 amRNSChange of Adviser
29th Nov 20217:00 amRNSTrading Update
8th Nov 20217:00 amRNSChannel Partner and Marketing Update
28th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSRelease of findings from Osirium Ransomware Index
20th Aug 20217:00 amRNSChange of Auditor
22nd Jul 20212:30 pmRNSResult of AGM
11th Jun 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSTotal Voting Rights
21st May 20214:00 pmRNSHolding(s) in Company
20th May 20219:05 amRNSHolding(s) in Company
19th May 20214:24 pmRNSHolding(s) in Company
12th May 20215:16 pmRNSResults of General Meeting
4th May 20217:00 amRNSTotal Voting Rights
30th Apr 202112:43 pmRNSHolding(s) in Company
29th Apr 20216:30 pmRNSHolding(s) in Company
29th Apr 20216:29 pmRNSHolding(s) in Company
27th Apr 20217:00 amRNSPublication of Circular & Notice of GM
23rd Apr 20217:00 amRNSResult of Placing and Subscription & TVR
22nd Apr 20214:41 pmRNSProposed Placing and Subscription & Notice of GM
11th Mar 20217:00 amRNSNHS Trust Customer Wins
1st Feb 20217:00 amRNSNew Patent Granted
15th Jan 20217:00 amRNSTrading Update
9th Dec 20207:00 amRNSContract win with additional UK Ambulance Service
4th Dec 20207:00 amRNSGrant of Options
2nd Dec 202011:05 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSContract win with major UK communications provider
10th Nov 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.